tirzepatide injection how long does it take to work For Work: Timeline Reviewed New Weight Loss Medical Advances.

These medications should be avoided by people who are pregnant or breastfeeding, those with a history of pancreatitis, and anyone with a personal or family history of medullary thyroid cancer or MEN2 syndrome

Semaglutide trials showed an average weight loss of approximately 15%, indicating that the medication alters baseline physiology but typically requires ongoing support to sustain results

As a precaution, these medications are not recommended for people with a personal or family history of thyroid cancer or specific genetic conditions that increase the risk of thyroid tumours

Limited evidence suggests it may help with modest blood sugar regulation after meals